Section 1 - National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017 - National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017

1National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017

Start here

Get a plain-English read of 1

Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017.

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 title: National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Determination 2017

?xml version="1.0" encoding="utf-8" standalone="no"?>

Commonwealth Coat of Arms of Australia

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017

PB 81 of 2017

made under section 84AH of the

National Health Act 1953

Compilation No. 25

Compilation date: 1 December 2025

Includes amendments: F2025L01444

About this compilation

This compilation

This is a compilation of the National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Determination 2017 that shows the text of the law as amended and in force on 1 December 2025 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au).

Application, saving and transitional provisions

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Presentational changes

The Legislation Act 2003 provides for First Parliamentary Counsel to make presentational changes to a compilation. Presentational changes are applied to give a more consistent look and feel to legislation published on the Register, and enable the user to more easily navigate those documents.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Listed Drug	Form (strength, type, size, etc.)	Manner of administration
Amisulpride	Oral solution 100 mg per mL, 60 mL	Oral
Amoxicillin	Powder for paediatric drops 100 mg (as trihydrate) per mL, 20 mL	Oral
Azithromycin	Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15mL	Oral
Atenolol	Oral solution 50 mg in 10 mL, 300 mL	Oral
Captopril	Oral solution 5 mg per mL, 95 mL	Oral
Carbamazepine	Oral suspension 100 mg per 5 mL, 300 mL	Oral
Ciclosporin	Oral liquid 100 mg per mL, 50 mL	Oral
Ciclosporin	Capsule 10 mg	Oral
Ciclosporin	Solution concentrate for I.V. infusion 50 mg in 1 mL	Injection
Ciprofloxacin	Ear drops 3 mg (as hydrochloride) per mL, 5 mL	Application to the ear
Clarithromycin	Powder for oral liquid 250 mg per 5 mL, 50 mL	Oral
Clonazepam	Oral liquid 2.5 mg per mL, 10 mL	Oral
Clonazepam	Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)	Injection
Diazepam	Oral liquid 10 mg per 10 mL, 100 mL	Oral
Diclofenac	Suppository containing diclofenac sodium 100 mg	Rectal
Digoxin	Paediatric oral solution 50 micrograms per mL, 60 mL	Oral
Escitalopram	Oral solution 20 mg (as oxalate) per mL, 15 mL	Oral
Ethosuximide	Oral solution 250 mg per 5 mL, 200 mL	Oral
Fluconazole	Powder for oral suspension 50 mg in 5 mL, 35 mL	Oral
Furosemide	Oral solution 10 mg per mL, 30 mL	Oral
Glyceryl Trinitrate	Sublingual spray (pump pack) 400 micrograms per dose, 200 doses	Sublingual
Indometacin	Suppository 100 mg	Rectal
Mercaptopurine	Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL	Oral
Methadone	Injection containing methadone hydrochloride 10 mg in 1 mL	Injection
Metronidazole	Suppositories 500 mg, 10	Rectal
Metronidazole	Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL	Oral
Nevirapine	Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL	Oral
Oxybutynin	Transdermal patches 36 mg, 8	Transdermal
Oxycodone	Oral solution containing oxycodone hydrochloride 1 mg per mL, 1 mL	Oral
Pantoprazole	Sachet containing granules 40 mg (as sodium sesquihydrate)	Oral
Paracetamol	Oral liquid 240 mg per 5 mL, 200 mL	Oral
Paracetamol	Suppository 500 mg	Rectal
Prochlorperazine	Injection containing prochlorperazine mesilate 12.5 mg in 1 mL	Injection
Salbutamol	Oral solution 2 mg (as sulfate) per 5 mL, 150 mL	Oral
Salbutamol	Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)	Inhalation by mouth
Terbinafine	Cream containing terbinafine hydrochloride 10 mg per g, 15 g	Application
Tofacitinib	Oral solution 1 mg per mL, 240 mL	Oral
Tramadol	Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL	Oral
Valganciclovir	Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL	Oral
Valproic Acid	Tablet, crushable, containing sodium valproate 100 mg	Oral
Valproic Acid	Oral liquid containing sodium valproate 200 mg per 5mL, 300 mL	Oral
Valproic Acid	Oral solution containing sodium valproate 200 mg per 5mL, 300 mL	Oral
Voriconazole	Powder for oral suspension 40 mg per mL, 70 mL	Oral

Listed Drug

Form (strength, type, size, etc.)

Manner of administration

Amisulpride

Oral solution 100 mg per mL, 60 mL

Oral

Amoxicillin

Powder for paediatric drops 100 mg (as trihydrate) per mL, 20 mL

Oral

Azithromycin

Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15mL

Oral

Atenolol

Oral solution 50 mg in 10 mL, 300 mL

Oral

Captopril

Oral solution 5 mg per mL, 95 mL

Oral

Carbamazepine

Oral suspension 100 mg per 5 mL, 300 mL

Oral

Ciclosporin

Oral liquid 100 mg per mL, 50 mL

Oral

Ciclosporin

Capsule 10 mg

Oral

Ciclosporin

Solution concentrate for I.V. infusion 50 mg in 1 mL

Injection

Ciprofloxacin

Ear drops 3 mg (as hydrochloride) per mL, 5 mL

Application to the ear

Clarithromycin

Powder for oral liquid 250 mg per 5 mL, 50 mL

Oral

Clonazepam

Oral liquid 2.5 mg per mL, 10 mL

Oral

Clonazepam

Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)

Injection

Diazepam

Oral liquid 10 mg per 10 mL, 100 mL

Oral

Diclofenac

Suppository containing diclofenac sodium 100 mg

Rectal

Digoxin

Paediatric oral solution 50 micrograms per mL, 60 mL

Oral

Escitalopram

Oral solution 20 mg (as oxalate) per mL, 15 mL

Oral

Ethosuximide

Oral solution 250 mg per 5 mL, 200 mL

Oral

Fluconazole

Powder for oral suspension 50 mg in 5 mL, 35 mL

Oral

Furosemide

Oral solution 10 mg per mL, 30 mL

Oral

Glyceryl Trinitrate

Sublingual spray (pump pack) 400 micrograms per dose, 200 doses

Sublingual

Indometacin

Suppository 100 mg

Rectal

Mercaptopurine

Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL

Oral

Methadone

Injection containing methadone hydrochloride 10 mg in 1 mL

Injection

Metronidazole

Suppositories 500 mg, 10

Rectal

Metronidazole

Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL

Oral

Nevirapine

Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL

Oral

Oxybutynin

Transdermal patches 36 mg, 8

Transdermal

Oxycodone

Oral solution containing oxycodone hydrochloride 1 mg per mL, 1 mL

Oral

Pantoprazole

Sachet containing granules 40 mg (as sodium sesquihydrate)

Oral

Paracetamol

Oral liquid 240 mg per 5 mL, 200 mL

Oral

Paracetamol

Suppository 500 mg

Rectal

Prochlorperazine

Injection containing prochlorperazine mesilate 12.5 mg in 1 mL

Injection

Salbutamol

Oral solution 2 mg (as sulfate) per 5 mL, 150 mL

Oral

Salbutamol

Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

Terbinafine

Cream containing terbinafine hydrochloride 10 mg per g, 15 g

Application

Tofacitinib

Oral solution 1 mg per mL, 240 mL

Oral

Tramadol

Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL

Oral

Valganciclovir

Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL

Oral

Valproic Acid

Tablet, crushable, containing sodium valproate 100 mg

Oral

Valproic Acid

Oral liquid containing sodium valproate 200 mg per 5mL, 300 mL

Oral

Valproic Acid

Oral solution containing sodium valproate 200 mg per 5mL, 300 mL

Oral

Voriconazole

Powder for oral suspension 40 mg per mL, 70 mL

Oral

ad = added or inserted	orig = original
am = amended	p = page(s)
amdt = amendment	para = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x	/sub‑subparagraph(s)
ch = Chapter(s)	pres = present
cl = clause(s)	prev = previous
cont. = continued	(prev…) = previously
def = definition(s)	pt = Part(s)
Dict = Dictionary	r = regulation(s)/Court rule(s)
disallowed = disallowed by Parliament	reloc = relocated
div = Division(s)	renum = renumbered
ed = editorial change	rep = repealed
exp = expires/expired or ceases/ceased to have	rs = repealed and substituted
effect	s = section(s)/subsection(s)
gaz = gazette	/rule(s)/subrule(s)/order(s)/suborder(s)
LA = Legislation Act 2003	sch = Schedule(s)
LIA = Legislative Instruments Act 2003	SLI = Select Legislative Instrument
(md) = misdescribed amendment can be given	SR = Statutory Rules
effect	sub ch = Sub‑Chapter(s)
(md not incorp) = misdescribed amendment	sub div = Subdivision(s)
cannot be given effect	sub pt = Subpart(s)
mod = modified/modification	underlining = whole or part not
No. = Number(s)	commenced or to be commenced
Ord = Ordinance

Name	Registration	Commencement	Application, saving and transitional provisions
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017 (PB 81 of 2017)	26 Sept 2017 (F2017L01265)	26 Sept 2017 (s 2)
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2017 (No. 1) (PB 90 of 2017)	30 Oct 2017 (F2017L01400)	1 Nov 2017 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 1) (PB 45 of 2018)	31 May 2018 (F2018L00694)	1 June 2018 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 2) (PB 61 of 2018)	29 June 2018 (F2018L00958)	1 July 2018 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 3) (PB 72 of 2018)	1 Aug 2018 (F2018L01074)	1 Aug 2018 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 4) (PB 97 of 2018)	26 Oct 2018 (F2018L01484)	1 Nov 2018 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2019 (No. 1) (PB 27 of 2019)	28 Mar 2019 (F2019L00451)	1 Apr 2019 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2019 (No. 2) (PB 44 of 2019)	30 May 2019 (F2019L00705)	1 June 2019 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2020 (No. 1) (PB 51 of 2020)	29 May 2020 (F2020L00651)	1 June 2020 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2020 (No. 2) (PB 63 of 2020)	30 June 2020 (F2020L00844)	1 July 2020 (s 2)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2020 (No. 3) (PB 120 of 2020)	27 Nov 2020 (F2020L01494)	1 Dec 2020 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 1) (PB 36 of 2021)	31 Mar 2021 (F2021L00385)	1 Apr 2021 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 2) (PB 68 of 2021)	30 June 2021 (F2021L00932)	1 July 2021 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 3) (PB 96 of 2021)	31 Aug 2021 (F2021L01222)	1 Sept 2021 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 4) (PB 107 of 2021)	30 Sept 2021 (F2021L01356)	1 Oct 2021 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2022 (No. 1) (PB 77 of 2022)	29 July 2022 (F2022L01018)	1 Aug 2022 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2022 (No. 2) (PB 126 of 2022)	23 Dec 2022 (F2022L01757)	1 Jan 2023 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 1) (PB 8 of 2023)	31 Jan 2023 (F2023L00070)	1 Feb 2023 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 2) (PB 77 of 2023)	31 July 2023 (F2023L01053)	1 Aug 2023 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 3) (PB 100 of 2023)	29 Sept 2023 (F2023L01342)	1 Oct 2023 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 4) (PB 122 of 2023)	30 Nov 2023 (F2023L01583)	1 Dec 2023 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2024 (No. 1) (PB 47 of 2024)	30 Apr 2024 (F2024L00497)	1 May 2024 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination (No. 1) 2025 (PB 80 of 2025)	27 June 2025 (F2025L00778)	1 July 2025 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination (No. 2) 2025 (PB 100 of 2025)	29 Aug 2025 (F2025L01017)	1 Sept 2025 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination (No. 3) 2025 (PB 116 of 2025)	30 Sept 2025 (F2025L01206)	1 Oct 2025 (s 2(1) item 1)	—
National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination (No. 4) 2025 (PB 143 of 2025)	27 Nov 2025 (F2025L01444)	1 Dec 2025 (s 2(1) item 1)	—

Name

Registration

Commencement

Application, saving and transitional provisions

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017 (PB 81 of 2017)

26 Sept 2017 (F2017L01265)

26 Sept 2017 (s 2)

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2017 (No. 1) (PB 90 of 2017)

30 Oct 2017 (F2017L01400)

1 Nov 2017 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 1) (PB 45 of 2018)

31 May 2018 (F2018L00694)

1 June 2018 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 2) (PB 61 of 2018)

29 June 2018 (F2018L00958)

1 July 2018 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 3) (PB 72 of 2018)

1 Aug 2018 (F2018L01074)

1 Aug 2018 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2018 (No. 4) (PB 97 of 2018)

26 Oct 2018 (F2018L01484)

1 Nov 2018 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2019 (No. 1) (PB 27 of 2019)

28 Mar 2019 (F2019L00451)

1 Apr 2019 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2019 (No. 2) (PB 44 of 2019)

30 May 2019 (F2019L00705)

1 June 2019 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2020 (No. 1) (PB 51 of 2020)

29 May 2020 (F2020L00651)

1 June 2020 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2020 (No. 2) (PB 63 of 2020)

30 June 2020 (F2020L00844)

1 July 2020 (s 2)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2020 (No. 3) (PB 120 of 2020)

27 Nov 2020 (F2020L01494)

1 Dec 2020 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 1) (PB 36 of 2021)

31 Mar 2021 (F2021L00385)

1 Apr 2021 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 2) (PB 68 of 2021)

30 June 2021 (F2021L00932)

1 July 2021 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 3) (PB 96 of 2021)

31 Aug 2021 (F2021L01222)

1 Sept 2021 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2021 (No. 4) (PB 107 of 2021)

30 Sept 2021 (F2021L01356)

1 Oct 2021 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2022 (No. 1) (PB 77 of 2022)

29 July 2022 (F2022L01018)

1 Aug 2022 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2022 (No. 2) (PB 126 of 2022)

23 Dec 2022 (F2022L01757)

1 Jan 2023 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 1) (PB 8 of 2023)

31 Jan 2023 (F2023L00070)

1 Feb 2023 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 2) (PB 77 of 2023)

31 July 2023 (F2023L01053)

1 Aug 2023 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 3) (PB 100 of 2023)

29 Sept 2023 (F2023L01342)

1 Oct 2023 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2023 (No. 4) (PB 122 of 2023)

30 Nov 2023 (F2023L01583)

1 Dec 2023 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination 2024 (No. 1) (PB 47 of 2024)

30 Apr 2024 (F2024L00497)

1 May 2024 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Amendment Determination (No. 1) 2025 (PB 80 of 2025)

27 June 2025 (F2025L00778)

1 July 2025 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination (No. 2) 2025 (PB 100 of 2025)

29 Aug 2025 (F2025L01017)

1 Sept 2025 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination (No. 3) 2025 (PB 116 of 2025)

30 Sept 2025 (F2025L01206)

1 Oct 2025 (s 2(1) item 1)

—

National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination (No. 4) 2025 (PB 143 of 2025)

27 Nov 2025 (F2025L01444)

1 Dec 2025 (s 2(1) item 1)

—

Provision affected	How affected
s 2.....................	rep LA s 48D
s 3.....................	rep LA s 48C
Schedule
Schedule.................	am F2017L01400; F2018L00694; F2018L00958; F2018L01074; F2018L01484; F2019L00451; F2019L00705; F2020L00651; F2020L00844; F2020L01494; F2021L00385; F2021L00932; F2021L01222; F2021L01356; F2022L01018; F2022L01757; F2023L00070; F2023L01053; F2023L01342; F2023L01583; F2024L00497; F2025L00778; F2025L01017; F2025L01206; F2025L01444